%0 Journal Article
%T Successful Treatment of Afatinib-Refractory Non-Small Cell Lung Cancer with Uncommon Complex EGFR Mutations Using Pembrolizumab: A Case Report
%A Hideyuki Takeshima
%A Hiroaki Ikushima
%A Kazuhiro Usui
%A Momoko Yamamoto
%A Sayaka Ohara
%A Toshio Sakatani
%A Yuri Taniguchi
%J Archive of "Case Reports in Oncology".
%D 2019
%R 10.1159/000501848
%K Afatinib
%K EGFR uncommon mutation
%K Immune-checkpoint inhibitor
%K Non-small-cell lung cancer
%K Pembrolizumab
%U https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6696780/